O-GlcNAcylation, OGT, and OGA expression was measured in nine age and sex matched control and AD post-mortem human brains finding an increase in O-GlcNAc levels and a decline in OGA expression in AD (Förster et al., 2014). The gene discussed is OGA; the disease is Alzheimer disease.